Top Stories
Suzlon Energy Q4 results: Revenue jumps 45%, EBITDA rises 39% YoY Crude down 5.45% on MCX but gold and silver barely moved — the USDINR effect explained Petrol crosses ₹100 in Delhi for first time as 4th fuel hike in 12 days adds ₹2.61 per litre Hindalco Industries Q4 Results: EBITDA crosses ₹10,000 crore; revenue jumps 20% YoY RBI to transfer record Rs 2.87 lakh crore dividend to government for FY26; balance sheet expands 20.61% Sun Pharma Q4 Results: Net profit rises 26.2% YoY, EBITDA grows over 6% Info Edge Q4 results: Revenue up 17%, operating margins improve 639 bps YoY Supreme Court to hear PIL against CBSE’s compulsory third language rule for Class 9 students next week Suzlon Energy Q4 results: Revenue jumps 45%, EBITDA rises 39% YoY Crude down 5.45% on MCX but gold and silver barely moved — the USDINR effect explained Petrol crosses ₹100 in Delhi for first time as 4th fuel hike in 12 days adds ₹2.61 per litre Hindalco Industries Q4 Results: EBITDA crosses ₹10,000 crore; revenue jumps 20% YoY RBI to transfer record Rs 2.87 lakh crore dividend to government for FY26; balance sheet expands 20.61% Sun Pharma Q4 Results: Net profit rises 26.2% YoY, EBITDA grows over 6% Info Edge Q4 results: Revenue up 17%, operating margins improve 639 bps YoY Supreme Court to hear PIL against CBSE’s compulsory third language rule for Class 9 students next week

Glenmark Pharmaceuticals Share Price

Glenmark Pharmaceuticals (NSE: GLENMARK) — live NSE quote, intraday chart, 52-week range, peers and latest news.

Healthcare

₹2,337.00
▲ +77.90 (+3.45%)
Intraday +77.90 (+3.45%)
09:15 Prev Close ₹2,259.10 15:30
Open 2,268.10
High 2,363.40
Low 2,268.10
Prev Close 2,259.10
Volume 8.09 L
52-Week High 2,474.00
52-Week Low 1,370.00
Updated: May 25, 2026, 04:46 PM IST
52-Week Range 5.54% below high · 70.58% above low
₹2,337.00
Low ₹1,370.00 High ₹2,474.00

Latest News on Glenmark Pharmaceuticals

View all Glenmark Pharmaceuticals news →